Autoimmunity and transplantation: a meeting at the crossroads in Berlin
暂无分享,去创建一个
H. Volk | P. Reinke | L. Turka | K. Wood | B. Sawitzki
[1] V. Sharma,et al. HLA-mismatched renal transplantation without maintenance immunosuppression. , 2008, The New England journal of medicine.
[2] J. Verdebout,et al. Endotoxin hyperresponsiveness upon CD4+ T cell reconstitution in lymphopenic mice: control by natural regulatory T cells , 2008, European journal of immunology.
[3] L. Turka,et al. Allograft rejection mediated by memory T cells is resistant to regulation , 2007, Proceedings of the National Academy of Sciences.
[4] D. Greiner,et al. Type 1 IFN Mediates Cross-Talk between Innate and Adaptive Immunity That Abrogates Transplantation Tolerance12 , 2007, The Journal of Immunology.
[5] G. Pantaleo,et al. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Rαhigh cell population in solid organ transplant recipients , 2007, The Journal of experimental medicine.
[6] L. Turka,et al. The Innate Immune System in Allograft Rejection and Tolerance1 , 2007, The Journal of Immunology.
[7] H. Volk,et al. Identification of Gene Markers for the Prediction of Allograft Rejection or Permanent Acceptance , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] M. Ehrenstein,et al. Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β , 2007, The Journal of experimental medicine.
[9] S. Akira,et al. TLR Engagement Prevents Transplantation Tolerance , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] I. Colle,et al. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] Chung-Che Chang,et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals , 2006, Nature Medicine.
[12] Ludwig Kappos,et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. , 2006, The New England journal of medicine.
[13] David C. Gondek,et al. Mast cells are essential intermediaries in regulatory T-cell tolerance , 2006, Nature.
[14] H. Volk,et al. Rat Cytomegalovirus Infection Interferes with Anti‐CD4 mAb‐(RIB 5/2) Mediated Tolerance and Induces Chronic Allograft Damage , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] J. Markmann,et al. Accelerated Memory Cell Homeostasis during T Cell Depletion and Approaches to Overcome It , 2006, The Journal of Immunology.
[16] C. Rooney,et al. HLA type‐independent generation of antigen‐specific T cells for adoptive immunotherapy , 2005, European journal of immunology.
[17] Michel Goldman,et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. , 2005, The New England journal of medicine.
[18] D. Zélénika,et al. Regulatory T Cells Overexpress a Subset of Th2 Gene Transcripts1 , 2002, The Journal of Immunology.
[19] L. Chatenoud,et al. Transforming Growth Factor-β and Natural Killer T-Cells Are Involved in the Protective Effect of a Bacterial Extract on Type 1 Diabetes , 2006 .
[20] Malou M-Louise Haine,et al. De Wilde V. , 1986 .